Freya Meds Review

Our assessment

Freya Meds puts a monthly plan and a quarterly plan for each drug in one table, and itemizes what the figure covers right down to the dietitian session. It never uses the word compounded on either page that carries a price. You only learn what formulation you are buying if you open the Terms.

Two terms, both drugs, one table

Each product page carries the same comparison block: a monthly rate and a quarterly rate for semaglutide and for tirzepatide, with the quarterly one marked billed and delivered quarterly. Nothing has to be reconstructed from a plan selector.

The block also names a standard starting dose and a maximum dose beside each figure, which makes the price comparable against sellers that price by dose step rather than flat.

The formulation is in the Terms, not on the price page

Neither priced page uses the word compounded. The Terms use it repeatedly, and state plainly that compounded medications including GLP-1 receptor agonists are not reviewed or approved by the Food and Drug Administration for safety, efficacy or manufacturing.

That is an adequate disclosure in the wrong place. Skip the Terms and you see two drug names, two prices and no indication that what arrives is a compounded preparation rather than the approved product.

So open the Terms before you buy. It is the only page on the site that answers the question.

What the price covers

The table lists the medication, unlimited doctor consultations, monthly group calls and a one-to-one consultation with the seller's dietitian, with cancellation at any time. Nothing is charged separately; sixty-three of the four hundred and twenty sellers here publish a figure that already covers everything.

The gaps are the ordinary ones. No compounding pharmacy is named, no individual clinician is named, and no service area is published.

The Terms also name an operating corporation whose name differs from the copyright agent listed on the same page.